About Alif Saleh
Alif Saleh is chief executive officer of 28bio. The company engineers human brains and produces predictive data for neurological drug development. He has raised more than half a billion dollars to develop and commercialize new life science and biotechnology technologies.
He was previously chief executive officer of Scipher Medicine Corporation and senior vice president of GC International Corporation. He also held product management and commercial positions with Alfa Laval in Europe and Asia. The Healthcare Technology Report named him one of its Top 50 Healthcare Technology CEOs in 2022. He holds an MSc in Chemical and Genetic Engineering from Lund Institute of Technology in Sweden.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Alif Saleh in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Alif Saleh works with at each company, as listed on that company's latest Form D.
